Knott David M Jr »

Enliven Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2026-06-30 $314k 6.2k 50.75

More positions owned by Knott David M Jr

Alphabet Inc-Cl C Common (GOOG)
Apollo Global Management Common (APO)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
Iovance Biotherapeutics Common (IOVA)
Alkermes Common (ALKS)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
LPL Financial Holdings Common
Cogent Biosciences Common (COGT)
TG Therapeutics Common (TGTX)
Catalyst Pharmaceuticals Common (CLST)

View all positions for Knott David M Jr

Top funds holding Enliven Therapeutics

FMR
OrbiMed Advisors
Polar Capital Holdings
BlackRock
Vestal Point Capital
Commodore Capital
Vanguard Capital Management
Citadel Advisors
Fairmount Funds Management
Siren
Bellevue Group
Geode Capital Management
First Light Asset Management
Pictet Asset Management Holding SA
State Street Corporation

View all funds holding Enliven Therapeutics